LU85264A1 - Composition adaptee a reduire la pression intraoculaire - Google Patents

Composition adaptee a reduire la pression intraoculaire Download PDF

Info

Publication number
LU85264A1
LU85264A1 LU85264A LU85264A LU85264A1 LU 85264 A1 LU85264 A1 LU 85264A1 LU 85264 A LU85264 A LU 85264A LU 85264 A LU85264 A LU 85264A LU 85264 A1 LU85264 A1 LU 85264A1
Authority
LU
Luxembourg
Prior art keywords
sulfonamide
cornea
solution
carbonic anhydrase
intraocular pressure
Prior art date
Application number
LU85264A
Other languages
English (en)
French (fr)
Inventor
Thomas H Maren
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of LU85264A1 publication Critical patent/LU85264A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LU85264A 1980-07-09 1984-03-22 Composition adaptee a reduire la pression intraoculaire LU85264A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16722080A 1980-07-09 1980-07-09
US16722080 1980-07-09

Publications (1)

Publication Number Publication Date
LU85264A1 true LU85264A1 (fr) 1984-11-14

Family

ID=22606448

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85264A LU85264A1 (fr) 1980-07-09 1984-03-22 Composition adaptee a reduire la pression intraoculaire

Country Status (15)

Country Link
EP (1) EP0044134B1 (de)
JP (1) JPH0245604B2 (de)
AT (1) ATE13632T1 (de)
BE (1) BE899314A (de)
CA (2) CA1193546A (de)
CH (1) CH659585A5 (de)
DE (2) DE3170818D1 (de)
FR (1) FR2560769B1 (de)
GR (1) GR74616B (de)
IE (1) IE52065B1 (de)
LU (1) LU85264A1 (de)
NL (1) NL191879C (de)
PT (1) PT73152B (de)
SE (1) SE455919B (de)
WO (1) WO1982000096A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2155331B (en) * 1980-07-09 1988-09-01 Florida University Of Composition for reducing intraocular pressure
WO1982000096A1 (en) * 1980-07-09 1982-01-21 Maren T Process for reducing intraocular pressure
US5095026A (en) * 1983-02-04 1992-03-10 University Of Iowa Research Foundation Prodrugs of carbonic anhydrase inhibitors
US4865584A (en) * 1984-02-08 1989-09-12 Omni-Flow, Inc. Cassette for programable multiple input infusion system
US4678855A (en) * 1985-10-09 1987-07-07 Merck & Co., Inc. Substituted benzenesulfonamides
US4873239A (en) * 1987-01-29 1989-10-10 Hoechst-Roussel Pharmaceuticals, Inc. Arylthiadiazolylsulfonamides and derivatives
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
US5573007A (en) * 1994-08-08 1996-11-12 Innerspace, Inc. Gas column pressure monitoring catheters
FR2734581B1 (fr) 1995-05-24 1997-08-14 Europ Propulsion Fil hybride pour la fabrication de preformes fibreuses de pieces en materiau composite et procede pour sa preparation
US6337340B1 (en) * 1998-08-14 2002-01-08 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
PL218655B1 (pl) 2009-05-05 2015-01-30 Franc Gardiner Spółka Z Ograniczoną Odpowiedzialnością Mechanizm blokujący ruch obrotowy wałka nawojowego rolety o napędzie sprężynowym, zwłaszcza rolety okiennej

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
FR2468366A1 (fr) * 1979-10-31 1981-05-08 Stoclet Alain Medicament antiglaucomateux a base d'acetazolamide ou de methazolamide
WO1982000096A1 (en) * 1980-07-09 1982-01-21 Maren T Process for reducing intraocular pressure
DE3102593A1 (de) * 1981-01-27 1982-09-02 Dr. Thilo & Co GmbH, 8021 Sauerlach Arzneimittelzubereitung zur anwendung am auge

Also Published As

Publication number Publication date
EP0044134A2 (de) 1982-01-20
FR2560769B1 (fr) 1987-11-13
PT73152B (en) 1987-08-17
CA1192560A (en) 1985-08-27
GR74616B (de) 1984-06-29
ATE13632T1 (de) 1985-06-15
SE8401281D0 (sv) 1984-03-07
NL8400804A (nl) 1985-10-01
NL191879C (nl) 1996-10-04
EP0044134B1 (de) 1985-06-05
BE899314A (fr) 1984-10-02
WO1982000096A1 (en) 1982-01-21
IE811235L (en) 1982-01-09
NL191879B (nl) 1996-06-03
JPH0245604B2 (de) 1990-10-11
IE52065B1 (en) 1987-06-10
FR2560769A1 (fr) 1985-09-13
DE3170818D1 (en) 1985-07-11
SE455919B (sv) 1988-08-22
CH659585A5 (de) 1987-02-13
JPS57500978A (de) 1982-06-03
SE8401281L (sv) 1985-09-08
DE3411104A1 (de) 1985-10-03
PT73152A (en) 1981-07-01
CA1193546A (en) 1985-09-17
EP0044134A3 (en) 1982-04-28

Similar Documents

Publication Publication Date Title
LU85264A1 (fr) Composition adaptee a reduire la pression intraoculaire
KR100757656B1 (ko) 알파 2-아드레날린 작용제 성분을 함유하는 조성물
EP1858481B1 (de) Ophthalmologische zusammensetzungen und ihre verwendung
CA2147123C (en) Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
KR100610997B1 (ko) 녹내장과 연관된 시신경 퇴화 방지용 약제를 제조하기 위한 나트륨 채널 차단제의 용도
EP1067966B1 (de) Betablocker enthaltende ophtalmische zusammensetzungen
Matsumoto et al. Characterization of gastric mucosal blood flow response induced by intragastric capsaicin in rats
RU2465898C2 (ru) Модуляторы связывания pai-1 для лечения глазных болезней
JPH01502829A (ja) 緑内障または高眼圧の局所治療用組成物
Kim et al. Alpha-adrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum
Yanagisawa et al. The effect of a substance P antagonist on chemically induced nociceptive reflex in the isolated spinal cord-tail preparation of the newborn rat
Day et al. Aortic occlusion and reperfusion and conduction, blood flow, and the blood-nerve barrier of rat sciatic nerve
CONROY Sulfonamides do not reach the retina in therapeutic amounts after topical application to the cornea
Gronbech et al. Role of sensory afferent neurons in hypertonic damage and restitution of the rat gastric mucosa
AU2007234903B2 (en) Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
EP0356355A1 (de) Ophthalmische Flüssigkeit als Sonnenbrille
US20040214829A1 (en) Compositions containing alpha-2-adrenergic agonist components
Ko et al. Histological study of mechanisms of adaptive cytoprotection on ethanol-induced mucosal damage in rat stomachs
SCHOENWALD et al. The ocular pharmacokinetics of ketanserin and its metabolite, ketanserinol, in albino rabbits
GB2155331A (en) Composition for reducing intraocular pressure
FR3109524A1 (fr) Utilisation d’un ligand multifonctionnel pour traiter l’œil sec et les dysfonctionnements des glandes de Meibomius et des glandes lacrymales.
IE57028B1 (en) Composition for reducing intraocular pressure
CA2255202A1 (fr) Utilisation de la flavine-adenine-dinucleotide pour la preparation de compositions ophtalmiques utiles pour le traitement de l'oeil sec
Wang et al. Vascular and platelet pharmacology of 2‐camphanone, a new drug for the treatment of hemorrhoids
SODA et al. The effect of brimonidine on intraocular pressure via the central nervous system in the conscious pigmented rabbit